148 related articles for article (PubMed ID: 10524541)
21. [Association of polymorphism of human beta 2-adrenergic receptor gene and bronchial asthma].
Gao JM; Lin YG; Qiu CC; Gao J; Ma Y; Liu YW; Liu Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):626-31. PubMed ID: 12905693
[TBL] [Abstract][Full Text] [Related]
22. Association between nonspecific airway hyperresponsiveness and Arg16Gly beta2-adrenergic receptor gene polymorphism in asymptomatic healthy Japanese subjects.
Fukui Y; Hizawa N; Takahashi D; Maeda Y; Jinushi E; Konno S; Nishimura M
Chest; 2006 Aug; 130(2):449-54. PubMed ID: 16899844
[TBL] [Abstract][Full Text] [Related]
23. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
24. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing.
Martinez FD; Graves PE; Baldini M; Solomon S; Erickson R
J Clin Invest; 1997 Dec; 100(12):3184-8. PubMed ID: 9399966
[TBL] [Abstract][Full Text] [Related]
25. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.
Bleecker ER; Postma DS; Lawrance RM; Meyers DA; Ambrose HJ; Goldman M
Lancet; 2007 Dec; 370(9605):2118-25. PubMed ID: 18156033
[TBL] [Abstract][Full Text] [Related]
26. Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD.
Hizawa N; Makita H; Nasuhara Y; Betsuyaku T; Itoh Y; Nagai K; Hasegawa M; Nishimura M
Chest; 2007 Nov; 132(5):1485-92. PubMed ID: 17890463
[TBL] [Abstract][Full Text] [Related]
27. Regular inhaled salbutamol and airway responsiveness to allergen.
Cockcroft DW; McParland CP; Britto SA; Swystun VA; Rutherford BC
Lancet; 1993 Oct; 342(8875):833-7. PubMed ID: 8104272
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms in the beta2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers.
Joos L; Weir TD; Connett JE; Anthonisen NR; Woods R; Paré PD; Sandford AJ
Thorax; 2003 Aug; 58(8):703-7. PubMed ID: 12885990
[TBL] [Abstract][Full Text] [Related]
29. Effects of genetic polymorphism on ex vivo and in vivo function of beta2-adrenoceptors in asthmatic patients.
Lipworth BJ; Hall IP; Tan S; Aziz I; Coutie W
Chest; 1999 Feb; 115(2):324-8. PubMed ID: 10027427
[TBL] [Abstract][Full Text] [Related]
30. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial.
Israel E; Chinchilli VM; Ford JG; Boushey HA; Cherniack R; Craig TJ; Deykin A; Fagan JK; Fahy JV; Fish J; Kraft M; Kunselman SJ; Lazarus SC; Lemanske RF; Liggett SB; Martin RJ; Mitra N; Peters SP; Silverman E; Sorkness CA; Szefler SJ; Wechsler ME; Weiss ST; Drazen JM;
Lancet; 2004 Oct 23-29; 364(9444):1505-12. PubMed ID: 15500895
[TBL] [Abstract][Full Text] [Related]
31. The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol.
Lee DK; Currie GP; Hall IP; Lima JJ; Lipworth BJ
Br J Clin Pharmacol; 2004 Jan; 57(1):68-75. PubMed ID: 14678342
[TBL] [Abstract][Full Text] [Related]
32. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
[TBL] [Abstract][Full Text] [Related]
33. beta-2 Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians.
Gratze G; Fortin J; Labugger R; Binder A; Kotanko P; Timmermann B; Luft FC; Hoehe MR; Skrabal F
Hypertension; 1999 Jun; 33(6):1425-30. PubMed ID: 10373227
[TBL] [Abstract][Full Text] [Related]
34. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma.
Israel E; Drazen JM; Liggett SB; Boushey HA; Cherniack RM; Chinchilli VM; Cooper DM; Fahy JV; Fish JE; Ford JG; Kraft M; Kunselman S; Lazarus SC; Lemanske RF; Martin RJ; McLean DE; Peters SP; Silverman EK; Sorkness CA; Szefler SJ; Weiss ST; Yandava CN
Am J Respir Crit Care Med; 2000 Jul; 162(1):75-80. PubMed ID: 10903223
[TBL] [Abstract][Full Text] [Related]
35. Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response.
Bhagat R; Swystun VA; Cockcroft DW
J Allergy Clin Immunol; 1996 Jan; 97(1 Pt 1):47-52. PubMed ID: 8568137
[TBL] [Abstract][Full Text] [Related]
36. beta2 adrenoceptor gene polymorphisms in cystic fibrosis lung disease.
Büscher R; Eilmes KJ; Grasemann H; Torres B; Knauer N; Sroka K; Insel PA; Ratjen F
Pharmacogenetics; 2002 Jul; 12(5):347-53. PubMed ID: 12142724
[TBL] [Abstract][Full Text] [Related]
37. Importance of beta(2)adrenergic receptor genotype, gender and race on albuterol-evoked bronchodilation in asthmatics.
Lima JJ; Mohamed MH; Self TH; Eberle LV; Johnson JA
Pulm Pharmacol Ther; 2000; 13(3):127-34. PubMed ID: 10873550
[TBL] [Abstract][Full Text] [Related]
38. Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis.
Turnes J; Hernández-Guerra M; Abraldes JG; Bellot P; Oliva R; García-Pagán JC; Bosch J
Hepatology; 2006 Jan; 43(1):34-41. PubMed ID: 16374847
[TBL] [Abstract][Full Text] [Related]
39. A methacholine challenge dose-response study for development of a pharmacodynamic bioequivalence methodology for albuterol metered- dose inhalers.
Creticos PS; Adams WP; Petty BG; Lewis LD; Singh GJ; Khattignavong AP; Molzon JA; Martinez MN; Lietman PS; Williams RL
J Allergy Clin Immunol; 2002 Nov; 110(5):713-20. PubMed ID: 12417879
[TBL] [Abstract][Full Text] [Related]
40. Diurnal change of bronchial caliber and airway responsiveness in asthmatics during long-term treatment with long-acting beta 2-agonist salmeterol.
Dottorini ML; Tantucci C; Peccini F; Grassi V; Sorbini CA
Int J Clin Pharmacol Ther; 1996 Oct; 34(10):438-43. PubMed ID: 8897082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
